Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Formation of protein kinase Cε-Lck signaling modules confers cardioprotection
Peipei Ping, … , William M. Pierce, Roberto Bolli
Peipei Ping, … , William M. Pierce, Roberto Bolli
Published February 15, 2002
Citation Information: J Clin Invest. 2002;109(4):499-507. https://doi.org/10.1172/JCI13200.
View: Text | PDF
Article

Formation of protein kinase Cε-Lck signaling modules confers cardioprotection

  • Text
  • PDF
Abstract

The ε isoform of protein kinase C (PKCε) is a member of the PKC family of serine/threonine kinases and plays a critical role in protection against ischemic injury in multiple organs. Functional proteomic analyses of PKCε signaling show that this isozyme forms multiprotein complexes in the heart; however, the precise signaling mechanisms whereby PKCε orchestrates cardioprotection are poorly understood. Here we report that Lck, a member of the Src family of tyrosine kinases, forms a functional signaling module with PKCε. In cardiac cells, PKCε interacts with, phosphorylates, and activates Lck. In vivo studies showed that cardioprotection elicited either by cardiac-specific transgenic activation of PKCε or by ischemic preconditioning enhances the formation of PKCε-Lck modules. Disruption of these modules, via ablation of the Lck gene, abrogated the infarct-sparing effects of these two forms of cardioprotection, indicating that the formation of PKCε-Lck signaling modules is required for the manifestation of a cardioprotective phenotype. These findings demonstrate, for the first time to our knowledge, that the assembly of a module (PKCε-Lck) is an obligatory step in the signal transduction that results in a specific phenotype. Thus, PKCε-Lck modules may serve as novel therapeutic targets for the prevention of ischemic injury.

Authors

Peipei Ping, Changxu Song, Jun Zhang, Yiru Guo, Xinan Cao, Richard C.X. Li, Wenjian Wu, Thomas M. Vondriska, Jason M. Pass, Xian-Liang Tang, William M. Pierce, Roberto Bolli

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
PKCε and Lck form functional signaling modules. (a) PKCε phosphorylated ...
PKCε and Lck form functional signaling modules. (a) PKCε phosphorylated GST-Lck. Lane 1: GST-Lck (86 kDa) and autophosphorylated PKCε (90 kDa); lane 2: autophosphorylated PKCε; lane 3: GST-Lck phosphorylated by PKA; lane 4: GST-Lck alone (negative control). (b) PKCε phosphorylates the SH2 domain, but not the GST-UD and GST- SH3 domains of Lck (lanes 1and 3). Lane 8 shows phosphorylation of GST-Lck by PKA (positive control). (c) PKCε phosphorylates S166 of Lck in vitro. Examples of mass spectrums. Upper panel: PKCε phosphorylates the SH2 domain (the phosphorylated peak [m/z value] of 1536.71 and the unphosphorylated peak of 1456.74). Middle panel: The mutated SH2 domain (the unphosphorylated peak of 1440.73 [S-A mutation shifted the m/z value]). Lower panel: PKCε does not phosphorylate the mutated SH2 (the unphosphorylated peak of 1440.73). (d) PKCε enhanced Lck activity in vitro. Lck activity was determined by phosphorylation of either enolase (upper panel) or Src substrates (lower panel). *P < 0.01 vs. GST-Lck. (e) Activation of PKCε (lanes 1–3) enhanced serine phosphorylation of Lck. Negative control with null vector (lanes 4–6). (f) Activation of PKCε via PKCε–adenoviruses enhanced Lck activity, which was blocked by GF109203, or by a PKCε dominant negative mutant (DN-PKCε) (12). *P < 0.05 vs. null vector, **P < 0.05 vs. PCKε. (g) Myocardial PKCε phosphorylates the SH2 domain of Lck. Transgenic (TG) PKCε enhances phosphorylation of wild-type (WT) SH2 (lane 2 versus lane 3), but not that of the mutant (MT) SH2 (lane 1). (h) Mutation of SH2 domain reduces Lck activity. PKCε-dependent Lck activity was reduced with SH2 mutant (Lck 166M, lanes 3 and 4) compared with that of the wild-type SH2 (Lck WT, lanes 1 and 2). Data are mean ± SEM.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts